Casi Pharmaceuticals (CASIF) Stock Price, News & Analysis
Company Description
Casi Pharmaceuticals (OTC Link: CASIF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $3.1M.
CASIF has gained 18.6% over the past month. Shares last traded at $0.1530.
For FY2025, Casi Pharmaceuticals reported revenue of $20.7M with net income of -$48.1M and diluted earnings per share of -$2.59. The company operates at a net profit margin of -232.0%.
This page collects what Stock Titan holds for CASIF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Casi Pharmaceuticals (CASIF) stock last closed at $0.1530. Over the past month, the stock has gained 18.6%. At a market capitalization of $3.1M, CASIF is classified as a micro-cap stock with approximately 20.6M shares outstanding.
CASIF Rankings
Latest News
Casi Pharmaceuticals has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include earnings. View all CASIF news →
SEC Filings
Casi Pharmaceuticals has filed 5 recent SEC filings, including 5 Form 6-K. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CASIF SEC filings →
Financial Highlights
Casi Pharmaceuticals generated $20.7M in revenue in FY2025, retaining a 48.6% gross margin, operating income reached -$45.0M (-217.3% operating margin), and net income was -$48.1M, reflecting a -232.0% net profit margin. Diluted earnings per share stood at -$2.59. The company generated -$20.8M in operating cash flow. With a current ratio of 0.27, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Casi Pharmaceuticals (CASIF) currently stands at 144.5 thousand shares, representing 1.4% of the float. Since February 2026, short interest has decreased by 67.9%. This relatively low short interest suggests limited bearish sentiment. With 35.2 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Casi Pharmaceuticals (CASIF) currently stands at 35.2 days, down 59.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 3420% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 87.0 days.
CASIF Company Profile & Sector Positioning
Casi Pharmaceuticals (CASIF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.